Safety and Efficacy of NRT6003 in Patients With Unresectable Hepatocellular Carcinoma

Conditions: Unresectable Hepatocellular Carcinoma Interventions: Drug: NRT6003 Injection Sponsors: Chengdu New Radiomedicine Technology Co. LTD. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials